Curious about weight changes after stopping GLP-1 drugs? Let's dive into the evidence on what happens with stopping and how to minimize the risk.
References:
-Xujia Lu et al. Habitual Coffee, Tea and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity. JCEM, 2024 DOI: 10.1210/clinem/dgae552
-Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022; 24(8): 1553-1564. doi:10.1111/dom.14725
-Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224
-Aronne LJ, et al "Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity" JAMA 2023; DOI: 10.1001/jama.2023.24945.
3 окт 2024
